The move beefs up the £170bn pharma group’s presence in the US, in a move designed to help it ‘reach a broader mix of global investors’.Read More
You might also be interested in reading Fidelity Investments Launches Crypto, Metaverse ETFs — Says ‘We Continue to See Demand’.